I’d love to have those links.
As you perhaps can tell from my Ivermectin links post, I was into that in a serious way, early. I knew about it late Spring/early Summer of 2020, bought my first horse paste in November 2020.
In all the reading I did, I of course came across the anti-cancer claims. One of my to-dos this year is to do a deep dive on that. I’ve been busy with a big life event (we’re moving), so haven’t done that yet, but I’m keenly interested in collecting resources/links for that future study.
š Later today... other obligations first.
All of my links are growing old - not that that negates them! This is a growing field of study - and likely to be resisted the same way as Hydroxycholorquine {HCQ}. {{In India HCQ saved millions of lives against CoViD; other countries similar. WE now know that NIH and FDA bureaucrats get a percentage kickback on high priced drugs. š }
This is on Gab, dated August, 2019; it has a collection of links, some involving another dog de-wormer: Levamisole, which was removed from the market.
That collection of links also includes This most quoted testimonial of May, 2019, which started all this hoopla about alternate cures for cancer, CoViD and who knows what all!
Here is a NIH PubMed article from November, 2008, connected with a Johns Hopkins University discovery of anti-cancer attributes of fenbendasole. It is an abstract and includes other similar links.
Here is a rather lengthy testimonial from July, 2020, but complete with later accepted recommendations of various vitamin and mineral OTC supplements that enhanced the curative effect of fenbendasole.
I have a file on this technical detailed clinical study on "Nature", August, 2018. Much to study and consider here.
I am certain that there are more recent clinical studies concerning the curative properties of these animal de-wormers - and re-formulated medicines more friendly to human consumption. Many may be foreign {but still available on NIH's PubMed} such as this Korean offering of February, 2020.
The hindrance of finding clinical studies about the efficacy of generic drugs for "off label" treatments is that "double blind" FDA approved clinical studies are costly and the result is to promote a cheap generic drug. I believe that massive public acceptance of the new therapeutic protocols would lead to accelerated sales prospects... but the pressure of established treatments and the overall financial arrangements do not encourage such studies.
It may come down to brave doctors and alternate medicine 'cults'. š If you find new links with compelling data about these 'off label' treatments for cancer or whatever, please contact me with the data. We at FR are trying to archive these possible cures in a time when normal medical procedures are under attack or being suppressed. Thank you. IR